US FDA requires GLP-1 drugmakers to add warning about potential eye risk
The changes must include information about a potentially increased risk of a rare but serious eye condition that can cause permanent vision loss.
We haven't written up this one. Free Malaysia Today has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- US FDA requires GLP-1 drugmakers to add warning about potential eye risk freemalaysiatoday.com